Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
25.34
-0.14 (-0.55%)
At close: Sep 17, 2026, 4:00 PM EDT
25.41
+0.07 (0.28%)
After-hours: Sep 17, 2026, 7:30 PM EDT
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,025,274
Profits / Employee
-$575
Market Cap
515.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| Capricor Therapeutics | 231 |
| Prime Medicine | 146 |
| Scribe Therapeutics | 82 |
| Tectonic Therapeutic | 60 |
| Contineum Therapeutics | 51 |
ASMB News
- 1 day ago - Assembly Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 days ago - Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference - GlobeNewsWire
- 9 days ago - Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - GlobeNewsWire
- 13 days ago - Assembly Biosciences Slides: Corporate presentation - Filings
- 16 days ago - Assembly Biosciences price target raised to $53 from $45 at Mizuho - TheFly
- 16 days ago - Assembly Biosciences initiated with a Buy at UBS - TheFly
- 4 weeks ago - Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TheFly
- 5 weeks ago - Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - GlobeNewsWire